Hepatocellular Carcinoma: The Role of Interventional Oncology

Publisher： Karger

E-ISSN： 1664-5553|6|1|34-43

ISSN： 2235-1795

Source： Liver Cancer, Vol.6, Iss.1, 2016-11, pp. : 34-43

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Cirrhosis in the Etiology of Hepatocellular Carcinoma

By Kew Michael  

Journal of Gastrointestinal Cancer, Vol. 45, Iss. 1, 2014-03 ,pp. : 12-21

Springer Publishing Company

Access to resources Recommend Favorite

Role of Percutaneous Ethanol Injection in the Treatment of Hepatocellular Carcinoma

By  

Digestive Diseases, Vol. 19, Iss. 4, 2002-03 ,pp. : 292-300

Karger

Access to resources Recommend Favorite

Role of Immunity in Pathogenesis and Treatment of Hepatocellular Carcinoma

By  

Digestive Diseases, Vol. 34, Iss. 4, 2016-05 ,pp. : 429-437

Karger

Access to resources Recommend Favorite

Adoption of Sorafenib for the Treatment of Advanced-Stage Hepatocellular Carcinoma in Oncology Practices in the United States

By  

Liver Cancer, Vol. 6, Iss. 3, 2017-04 ,pp. : 216-226

Karger

Access to resources Recommend Favorite

Hypotheses on the Role of Transforming Growth Factor-β in the Onset and Progression of Hepatocellular Carcinoma

By  

Digestive Diseases, Vol. 27, Iss. 2, 2009-06 ,pp. : 93-101

Karger

Access to resources Recommend Favorite